Generate a tailored SOP for Dr. Tamara Milder. Improve your application with a focused, well-structured draft.
I am a Senior Research Associate in the Medicines Intelligence Research Program in the School of Population Health at UNSW Sydney. I work as an endocrinologist at St Vincent's Clinic Randwick. My educational background includes a Bachelor of Medicine Bachelor of Surgery with Honours Class 1 from UNSW Sydney, a Master of Medicine in Clinical Epidemiology from the University of Sydney, and I am pursuing a Doctor of Philosophy (PhD) at UNSW Sydney, which I expect to complete in 2025. My doctoral research focuses on the effective and safe use of sodium-glucose cotransporter 2 inhibitors (SGLT2i), which are critical medications for treating type 2 diabetes, heart failure, and chronic kidney disease. My research primarily addresses pharmacotherapy related to cardiovascular-kidney-metabolic syndrome, specifically looking at SGLT2i and glucagon-like peptide-1 receptor agonists (GLP-1 RA). I have a strong clinical and academic interest in diabetes pharmacotherapy, particularly the major cardiac and renal benefits associated with these medications. I have implemented a mixed-methodology approach to explore the uptake of SGLT2i and GLP-1 RA among patients with type 2 diabetes throughout New South Wales, Australia, and identified a considerable underutilization of these critical therapies. Additionally, I have been involved in several studies examining the perioperative management of patients using SGLT2i and GLP-1 RA, and have published reviews on the subject.
Medicines Intelligence Research Program, UNSW Sydney • Sydney, Australia
Senior Research Associate focused on pharmacotherapy and implementation studies.
St Vincent's Clinic • Randwick, Australia
Providing specialist care in endocrinology with a focus on diabetes and cardiac renal health.
Includes Business Intelligence, Enterprise Systems, and Cybersecurity Management streams.